The baseline characteristics of the SGLT2i trials in patients with HFrEF showed that the populations of DAPA-HF had higher eGFR, lower NT-proBNP levels, and a reduced use of ARNI and cardiac resynchronization therapy than those of EMPEROR-REDUCED and SOLOIST-WHF. Here, NPPB is linked to hydrops fetalis.